Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

May 31, 2018

Primary Completion Date

August 11, 2020

Study Completion Date

August 3, 2021

Conditions
Moderate to Severe Atopic Dermatitis
Interventions
DRUG

ISB 830 - Part 1 Group 1

Subcutaneous injection (SC) every 2 weeks

DRUG

ISB 830 - Part 1 Group 2

Subcutaneous injection (SC) every 2 weeks

DRUG

ISB 830 - Part 1 Group 3

Subcutaneous injection (SC) every 2 weeks

DRUG

Placebo - Part 1 Group 4

Subcutaneous injection (SC) every 2 weeks

DRUG

ISB 830 - Part 2 Group 5

Subcutaneous injection (SC) every 2 weeks

DRUG

Placebo - Part 2 Group 6

Subcutaneous injection (SC) every 2 weeks

Trial Locations (83)

1069

Ichnos Investigational Site 309, Dresden

10117

Ichnos Investigational Site 319, Berlin

10789

Ichnos Investigational Site 304, Berlin

11375

Glenmark Investigational Site 102, Forest Hills

14050

Ichnos Investigational Site 326, Berlin

18201

Ichnos Investigational Site 133, Hazleton

19103

Ichnos Investigational Site 122, Philadelphia

22143

Ichnos Investigational Site 310, Hamburg

22391

Ichnos Investigational Site 308, Hamburg

23220

Ichnos Investigational Site 131, Richmond

23538

Ichnos Investigational Site 315, Lübeck

30263

Ichnos Investigational Site 115, Newnan

31406

Ichnos Investigational Site 139, Savannah

32055

Ichnos Investigational Site 148, Lake City

32174

Ichnos Investigational Site 147, Ormond Beach

33156

Ichnos Investigational Site 140, Miami

33175

Ichnos Investigational Site 123, Miami

33461

Ichnos Investigational Site 141, Lake Worth

33511

Ichnos Investigational Site 142, Brandon

33607

Ichnos Investigational site 101, Tampa

33612

Ichnos Investigational Site 135, Tampa

33647

Ichnos Investigational Site 322, Bielefeld

33912

Ichnos Investigational Site 143, Fort Myers

35209

Ichnos Investigational Site 129, Birmingham

37421

Ichnos Investigational Site 132, Chattanooga

44793

Ichnos Investigational Site 318, Bochum

46168

Ichnos Investigational Site 112, Plainfield

49074

Ichnos Investigational Site 314, Osnabrück

50265

Ichnos Investigational Site 125, West Des Moines

63141

Ichnos Investigational Site 126, St Louis

70115

Ichnos Investigational Site109, New Orleans

76710

Ichnos Investigational Site 110, Waco

77004

Ichnos Investigational Site 119, Houston

78258

Ichnos Investigational Site 116, San Antonio

78660

Ichnos Investigational Site 138, Pflugerville

88045

Ichnos Investigational Site 313, Friedrichshafen

89120

Ichnos Investigational Site 144, Las Vegas

89129

Ichnos Investigational Site 305, Langenau

90274

Ichnos Investigational Site 105, Rolling Hills Estates

91054

Ichnos Investigational Site 311, Erlangen

93711

Ichnos Investigational Site 120, Clovis

99224

Ichnos Investigational Site 136, Spokane

06606

Ichnos Investigational Site 106, Bridgeport

06810

Ichnos Investigational Site 146, Danbury

07044-2946

Ichnos Investigational Site 117, Verona

97504-9741

Ichnos Investigational Site 114, Medford

23606-4537

Ichnos Investigational Site 103, Newport News

T3A 2N1

Ichnos Investigational Site 202, Calgary

V3V 0C6

Ichnos Investigational Site 203, Surrey

R3M 3Z4

Ichnos Investigational Site 207, Winnipeg

L8N 3Z5

Ichnos Investigational Site 214, Hamilton

L3P 1X2

Ichnos Investigational Site 204, Markham

K1G 6C6

Ichnos Investigational Site 206, Ottawa

K2C 3N2

Ichnos Investigational Site 208, Ottawa

L4C 9M7

Ichnos Investigational Site 201, Richmond Hill

QC, J2B 5L

Ichnos Investigational Site 211, Drummondville

602 00

Ichnos Investigational Site 404, Brno

547 01

Ichnos Investigational Site 402, Náchod

130 00

Ichnos Investigational Site 403, Prague

702 00

Ichnos Investigational Site 401, Ostrava

530 02

Ichnos Investigational Site 405, Pardubice

110 00

Ichnos Investigational Site 407, Prague

568 02

Ichnos Investigational Site 406, Svitavy

01097

Ichnos Investigational Site 302, Dresden

60-702

Ichnos Investigational Site 518, Poznan

60-848

Ichnos Investigational Site 514, Poznan

30-033

Ichnos Investigational Site 502, Krakow

31-002

Ichnos Investigational Site 511, Krakow

31-011

Ichnos Investigational Site 510, Krakow

31-209

Ichnos Investigational Site 501, Krakow

51-124

Ichnos Investigational Site 504, Wroclaw

01-817

Ichnos Investigational Site 509, Warsaw

02-625

Ichnos Investigational Site 521, Warsaw

02-758

Ichnos Investigational Site 512, Warsaw

04-141

Ichnos Investigational Site 506, Warsaw

38-440

Ichnos Investigational Site 517, Iwonicz-Zdrój

81-338

Ichnos Investigational Site 519, Gdynia

81-384

Ichnos Investigational Site 520, Gdynia

71-270

Ichnos Investigational Site 513, Szczecin

40-851

Ichnos Investigational Site 503, Katowice

31-513

Ichnos Investigational Site 505, Krakow

26-110

Ichnos Investigational Site 508, Skarżysko-Kamienna

02-777

Ichnos Investigational Site 507, Warsaw

Sponsors
All Listed Sponsors
collaborator

Glenmark Pharmaceuticals S.A.

INDUSTRY

lead

Ichnos Sciences SA

INDUSTRY

NCT03568162 - Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter